Leadership

Erik Paulsen Chairman

Congressman Erik Paulsen (MN-3) served from 2009 to 2019 as a leading member on the House Ways and Means Committee, which has jurisdiction over healthcare, economic, and trade policy. Erik currently serves as Chairman of the Institute for Gene Therapies, a 501(c)(4) that brings together experts across the healthcare system to advocate for a modernized policy framework that encourages transformative innovations, promotes patient access, and codifies transparent reimbursement practices.

 

As a Member of Congress, Erik was the Chairman of the Joint Economic Committee focusing on innovation, entrepreneurship, digital trade, and other key economic issues. Erik also served as Co-Chair of the House Medical Technology Caucus and is a passionate advocate for innovative life science and medical technologies, the benefits they provide to patients, and the hundreds of thousands of jobs they support.

 

In addition, Erik was a member of the Deputy Whip Team and Co-Chaired the Digital Trade Caucus and the Transatlantic Trade and Investment Partnership Caucus to promote international trade.

 

Prior to his service in Congress, Erik was a member of the Minnesota State Legislature, where he served as House Majority Leader. Erik has over 16 years of business experience, including working as a business analyst at Target Corporation. He received his bachelor’s degree in mathematics from St. Olaf College and resides in Eden Prairie with his wife and their four daughters.

Mike Capaldi
Executive Director

Michael Capaldi is Executive Director for the Institute for Gene Therapies. Prior to this role, Michael completed a 22-year career at Sanofi, a global leader in pharmaceuticals, vaccines and biologics, where he acquired a broad set of experiences across multiple therapeutic areas. His career included roles  in public affairs leadership across diabetes, cardiovascular, oncology, cell & organ transplant, joint health and consumer health divisions.
 
Michael has also shared his time and expertise in a number of other roles benefiting the healthcare community. From 2006 to 2012, he served on the board of the Society of Pharmaceutical & Biotech Trainers, now L-TEN, and acted as President in 2011 and 2012.
 
Michael has a bachelor’s degree from the Ohio State University and earned a master’s in education for corporate training & knowledge management.

Lauren Randall Buckley
Director of Health Policy & Advocacy

Lauren Randall Buckley is the Director of Health Policy & Advocacy at the Institute for Gene Therapies. She has spent her career representing innovative healthcare technology companies before the Administration and Congress on cutting-edge federal regulatory, policy, and legislative issues. She possesses extensive depth in navigating complex Medicare and Medicaid coverage, coding, and payment issues; engaging in payment and delivery innovation model development; developing commercialization strategies; and building multi-faceted tactical plans to advance policy priorities.


Lauren previously led the U.S. federal health policy portfolio for MedImmune, the biotechnology arm of AstraZeneca. She practiced law for many years in the Healthcare Regulatory practice group at Sidley Austin, after beginning her career as an associate at DLA Piper.

Lauren holds a Juris Doctor degree from the Washington College of Law at American University and a Bachelor of Science degree in Marketing from the Pennsylvania State University, Schreyer Honors College.

high res logo.png

The Institute for Gene Therapies advocates for a modernized regulatory and reimbursement framework that encourages the development of transformative gene therapies and promotes patient access. 

Get In Touch

IGT. © 2020 All Rights Reserved